While the Gilead: Hepatitis-C Access Strategy (A) case (515-025) poses questions on what the business should do with respect to hard hit nations like Egypt and India, this (B) case supplies the response.
In both cases, the business chose to continue a proactive strategy to enable accessibility at reasonable prices.
PUBLICATION DATE: October 29, 2014 PRODUCT #: 515044-HCC-ENG
This is just an excerpt. This case is about SALES & MARKETING